A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female Participants
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at how the body processes oral contraceptive (OC), using
Ortho-Cyclen, as a commonly prescribed combination oral contraceptive in healthy female
participants, and the effect of dulaglutide on how Ortho-Cyclen is processed by the body.
Information about any side effects that may occur will also be collected.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Contraceptive Agents Contraceptives, Oral Dulaglutide Fluoroquinolones Immunoglobulin Fc Fragments Moxifloxacin Norgestimate, ethinyl estradiol drug combination